Form 4 Tracker
GeneDx Holdings Corp.
WGS

43 insider filings · Latest: Sep 17, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Dec 9, 2024Dec 10 1:05 AMKatherine Stueland
Proposed Sale
3,661$76.37$279.6K—

View →

Dec 2, 2024Dec 3 1:01 AMKevin Feeley
Proposed Sale
263$78.39$20.6K—

View →

Nov 21, 2024Nov 21 11:14 PMFeeley Kevin
Proposed Sale
22,000$72.73$1.6M—

View →

Nov 19, 2024Nov 19 10:10 PMRyan Jason
Proposed Sale
47,000$70.00$3.3M—

View →

Nov 15, 2024Nov 15 9:58 PMStueland Katherine
Proposed Sale
45,415$70.02$3.2M—

View →

Oct 31, 2024Nov 1 12:03 AMICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Proposed Sale
1,012,941$81.69$82.7M—

View →

Oct 29, 2024Oct 29 11:45 PMKevin Feeley
Proposed Sale
274$66.60$18.2K—

View →

Oct 29, 2024Oct 29 11:44 PMKatherine Stueland
Proposed Sale
2,154$66.60$143.5K—

View →

Sep 17, 2024Sep 20 6:56 PMOPKO HEALTH, INC.
Proposed Sale
13,404$40.88$548.0K—

View →

Sep 16, 2024Sep 16 10:54 PMKevin Feeley
Proposed Sale
2,635$37.59$99.0K—

View →

Sep 16, 2024Sep 16 10:54 PMKatherine Stueland
Proposed Sale
10,501$37.59$394.7K—

View →

Sep 9, 2024Sep 10 1:03 AMKevin Feeley
Proposed Sale
895$33.33$29.8K—

View →

Sep 9, 2024Sep 10 1:03 AMKatherine Stueland
Proposed Sale
3,639$33.33$121.3K—

View →

Sep 3, 2024Sep 4 1:35 AMKevin Feeley
Proposed Sale
262$31.71$8.3K—

View →

← Previous

Page 5 of 5

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Sep 16, 2026Sep 18 8:43 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
18,750—37,500(D)

View →

Sep 16, 2026Sep 18 8:39 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
7,197—14,393(D)

View →

Sep 17, 2026Sep 18 8:37 PMThomas FuchsDirector
Option Exercise
1,146—2,292(D)

View →

Sep 9, 2026Sep 11 8:13 PMKatherine StuelandDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
6,547—6,547(D)

View →

Sep 9, 2026Sep 11 8:10 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
2,462—2,463(D)

View →

Sep 1, 2026Sep 3 8:09 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
717—0(D)

View →

Jun 29, 2026Jul 1 8:10 PMMark A GardnerPresident
Grant/Award
35,441—35,441(D)

View →

Jun 18, 2026Jun 23 8:31 PMJason RyanDirector
Option Exercise
3,576—0(D)

View →

Jun 18, 2026Jun 23 8:30 PMRUCH JOSHUADirector
Option Exercise
3,576—0(D)

View →

Jun 18, 2026Jun 23 8:30 PMRUCH JOSHUADirector
Grant/Award
4,248—4,248(D)

View →

Jun 18, 2026Jun 23 8:29 PMRichard C Pfenniger JRDirector
Option Exercise
3,576—0(D)

View →

Jun 18, 2026Jun 23 8:29 PMRichard C Pfenniger JRDirector
Grant/Award
4,248—4,248(D)

View →

Jun 18, 2026Jun 23 8:28 PMKeith A. MeisterDirector, 10% Owner
Option Exercise
3,576—0(D)

View →

Jun 18, 2026Jun 23 8:28 PMKeith A. MeisterDirector, 10% Owner
Grant/Award
4,248—4,248(D)

View →

Jun 18, 2026Jun 23 8:27 PMEmily M. LeproustDirector
Grant/Award
4,248—4,248(D)

View →

Jun 18, 2026Jun 23 8:27 PMEmily M. LeproustDirector
Option Exercise
3,576—0(D)

View →

Jun 18, 2026Jun 23 8:26 PMThomas FuchsDirector
Grant/Award
4,248—4,248(D)

View →

Jun 18, 2026Jun 23 8:25 PMEli CasdinDirector, 10% Owner
Option Exercise
3,576—0(D)

View →

Jun 18, 2026Jun 23 8:25 PMEli CasdinDirector, 10% Owner
Grant/Award
4,248—4,248(D)

View →

Jun 16, 2026Jun 18 8:11 PMKevin FeeleyCHIEF FINANCIAL OFFICER
Option Exercise
7,197—21,590(D)

View →

Page 1 of 3

Next →